Trial · NCT03574597
Adverse events3,536
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 3,536
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Abdominal hernia | Gastrointestinal disorders | Semaglutide | 5 | 8,803 | 5 |
| serious | Abdominal hernia | Gastrointestinal disorders | Placebo | 6 | 8,801 | 6 |
| serious | Abdominal lymphadenopathy | Blood and lymphatic system disorders | Semaglutide | 0 | 8,803 | 0 |
| serious | Abdominal lymphadenopathy | Blood and lymphatic system disorders | Placebo | 1 | 8,801 | 1 |
| serious | Abdominal pain | Gastrointestinal disorders | Semaglutide | 9 | 8,803 | 10 |
| serious | Abdominal pain | Gastrointestinal disorders | Placebo | 18 | 8,801 | 19 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Semaglutide | 1 | 8,803 | 1 |
| serious | Abdominal pain lower | Gastrointestinal disorders | Placebo | 2 | 8,801 | 2 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Semaglutide | 11 | 8,803 | 12 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Placebo | 12 | 8,801 | 12 |
| serious | Abdominal strangulated hernia | Gastrointestinal disorders | Semaglutide | 0 | 8,803 | 0 |
| serious | Abdominal strangulated hernia | Gastrointestinal disorders | Placebo | 2 | 8,801 | 2 |
| serious | Abdominal symptom | Gastrointestinal disorders | Semaglutide | 1 | 8,803 | 1 |
| serious | Abdominal symptom | Gastrointestinal disorders | Placebo | 0 | 8,801 | 0 |
| serious | Abnormal behaviour | Psychiatric disorders | Semaglutide | 0 | 8,803 | 0 |
| serious | Abnormal behaviour | Psychiatric disorders | Placebo | 1 | 8,801 | 1 |
| serious | Abnormal uterine bleeding | Reproductive system and breast disorders | Semaglutide | 1 | 8,803 | 1 |
| serious | Abnormal uterine bleeding | Reproductive system and breast disorders | Placebo | 0 | 8,801 | 0 |
| serious | Abscess limb | Infections and infestations | Semaglutide | 2 | 8,803 | 2 |
| serious | Abscess limb | Infections and infestations | Placebo | 3 | 8,801 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03574597/events?page=2